Elizabeth Bright
Psychiatric/Mental Health · Shreveport, LANPI 1770138000
Payments from drug & device makers
Across 242 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$909
- Axsome Therapeutics, Inc.$603
- AbbVie$573
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$328
- Neurocrine Biosciences, Inc.$312
- plus $1K from 12 others
What the payments were for
- Speaking & faculty fees$60012%
- Food & beverage$4,27488%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $1,055 |
| Alkermes, Inc. | 53 | $909 |
| Axsome Therapeutics, Inc. | 12 | $603 |
| AbbVie | 56 | $573 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $328 |
| Neurocrine Biosciences, Inc. | 15 | $312 |
| Otsuka America Pharmaceutical, Inc. | 15 | $269 |
| Sunovion Pharmaceuticals Inc. | 16 | $170 |
| Supernus Pharmaceuticals, Inc. | 5 | $136 |
| Johnson & Johnson | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $113 |
| Corium, LLC | 6 | $87 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $36 |
| Bausch Health US, LLC | 2 | $32 |
| Tris Pharma Inc | 1 | $19 |
| Indivior Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,878 in reported general payments places this provider in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 13 | $21,800 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $16,176 |
| Clozapine | 25 | $695 |
| Doxepin Hcl | 11 | $495 |
| Bupropion XlBupropion Hcl | 24 | $394 |
| Oxcarbazepine | 21 | $346 |
| Duloxetine Hcl | 12 | $290 |
| Escitalopram Oxalate | 31 | $260 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $222 |
| Quetiapine Fumarate | 26 | $207 |
| Buspirone Hcl | 12 | $177 |
| Zolpidem Tartrate | 20 | $166 |
| Prazosin Hcl | 20 | $165 |
| Sertraline Hcl | 32 | $148 |
| Hydroxyzine Pamoate | 15 | $108 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $573 | $21,80013 claims |
| Axsome Therapeutics, Inc.Auvelity | $603 | $16,17619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Shreveport
- Kimberly ForcinelShreveport$92K
- Zachary FussellShreveport$9K
- Lisa BakerShreveport$9K
- Jaschandria BellShreveport$8K
- Shannon JacksonShreveport$8K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.